← Back to Search

Behavioural Intervention

Use of Zemedy Application for Irritable Bowel Syndrome

N/A
Waitlist Available
Led By Linda Nguyen, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Meet Rome IV criteria for IBS for at least 6 months. No restrictions on type of IBS.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at week 24.
Awards & highlights

Study Summary

This trial will test whether the Zemedy app can help people with IBS by providing a CBT program digitally.

Who is the study for?
This trial is for adults over 18 with Irritable Bowel Syndrome (IBS) who have had symptoms for at least 6 months. Participants must speak English, have been on a stable IBS treatment for 30 days, and own a smartphone to use the Zemedy app.Check my eligibility
What is being tested?
The study tests the effectiveness of Zemedy, a mobile app delivering cognitive behavioral therapy (CBT) programs to help manage IBS symptoms.See study design
What are the potential side effects?
Since Zemedy is an application providing CBT and not a medication, it may not have typical drug side effects. Users might experience discomfort if new to CBT or stress from regular engagement with the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with IBS for at least 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at week 24.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at week 24. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
IBS-SSS at 8 Weeks
Secondary outcome measures
IBS-SSS at 24 Weeks

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental (TAU plus CBT)Experimental Treatment1 Intervention
Subjects who are in the Experimental Group will receive 8 weeks of CBT from the Zemedy mobile application in addition to their treatment as usual (TAU).
Group II: Control Group (TAU only)Active Control1 Intervention
Treatment as Usual (TAU) for IBS patients are tailored to each individual's needs and may involve treatment such as: dietary modification, exercise, medication, and anti-diarrheal therapy.

Find a Location

Who is running the clinical trial?

Bold Health Inc.Industry Sponsor
2 Previous Clinical Trials
446 Total Patients Enrolled
2 Trials studying Irritable Bowel Syndrome
446 Patients Enrolled for Irritable Bowel Syndrome
Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,333,986 Total Patients Enrolled
3 Trials studying Irritable Bowel Syndrome
244 Patients Enrolled for Irritable Bowel Syndrome
Linda Nguyen, MDPrincipal InvestigatorStanford University
5 Previous Clinical Trials
644 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being recruited for this investigation?

"According to clinicaltrials.gov, this medical investigation is actively recruiting patients since its posting on October 15th 2021. The information was last revised on May 26th 2022."

Answered by AI

What is the maximum enrollment capacity for this research project?

"Affirmative. The information posted on clinicaltrials.gov evidences that this medical experiment, which was initially publicized on October 15th 2021, is actively searching for subjects. 44 individuals need to be recruited from one research institute."

Answered by AI

Who else is applying?

What state do they live in?
West Virginia
How old are they?
65+
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Recent research and studies
clinicaltrials.govStudy
Zemedy Application for Irritable Bowel Syndrome
Linda Nguyen 2021. "Zemedy Application for Irritable Bowel Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04723056.
All > Irritable Bowel Syndrome > Ibs
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top